Registry of Lobbyists

Monthly Communication Report

Return to Registration for Innovative Medicines Canada / Médicaments novateurs Canada

15042-590016

Corporation: AstraZeneca Canada Inc.
Associated registration: 949884-15042-56
Communication date: 2023-12-12
Posted date: 2024-01-15

Designated Public Office Holders who participated in the communication: Suzy McDonald, Associate Deputy Minister
Finance Canada (FIN)

Mathew Sajkunovic, Director General
Microeconomic Policy Analysis, Finance Canada (FIN)
 
Subject Matter of the communication: Industry
 
Responsible Officer who filed this communication report: Kiersten Combs
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Return to Registration for Innovative Medicines Canada / Médicaments novateurs Canada
Date Modified: